Sep 04, 2025

TPG Asia VII SF Pte Ltd in relation to the sale of its 14.72% stake in Sai Life Sciences Limited.

AZB & Partners advised TPG Asia VII SF Pte Ltd (the “Seller”) in relation to the sale of its 14.72% stake in Sai Life Sciences Limited for an amount aggregating to approximately INR 26.76 billion. The sale took place on the floor of the stock exchanges via the screen-based trading platform. The brokers to the transaction were IIFL Capital Services Limited, Kotak Securities Limited and Jefferies India Private Limited.

The AZB team advising the Seller comprised our Senior Partner, Varoon Chandra, our Partner, Rahul Aggarwal and our Associate, Yagnesh Sharma.

AUTHORS & CONTRIBUTORS

TAGS

SHARE

DISCLAIMER

These are the views and opinions of the author(s) and do not necessarily reflect the views of the Firm. This article is intended for general information only and does not constitute legal or other advice and you acknowledge that there is no relationship (implied, legal or fiduciary) between you and the author/AZB. AZB does not claim that the article's content or information is accurate, correct or complete, and disclaims all liability for any loss or damage caused through error or omission.